MIRA
INFORM REPORT
|
Report Date : |
18.12.2007 |
IDENTIFICATION
DETAILS
|
Name : |
UNIVERSAL PHARMACEUTICALS (PVT) LIMITED |
|
|
|
|
Registered Office : |
Yousafzai House, Bilal Town, G.T. Road, Peshawar |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
2001 |
|
|
|
|
Com. Reg. No.: |
0042953 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Business Name
UNIVERSAL PHARMACEUTICALS (PVT) LIMITED
Full Address
Registered Address
Yousafzai House, Bilal Town, G.T. Road, Peshawar, Pakistan.
Tel 92 (91) 5829766, 7100867
Fax 92 (91) 5830768
Email Not Available
Factory Address
131-A,
Industrial Estate, Hayatabad, Peshawar, Pakistan.
Short Description Of Business
|
Nature of Business |
Manufacture & Marketing of Pharmaceutical Products |
|
Year Established |
2001 |
|
Registration # |
0042953 (Old Registration # was 00000002056/20011006) |
Branches
None
Auditors
Tariq Ayub Anwar & Co.
(Chartered
Accountants)
14-A, Haroon Mansion, Khyber Bazar, Peshawar, Pakistan.
Legal Status
Subject Company was established as a Private Limited Company in 2001
|
Authorized Capital |
Rs. 10,000,000/- divided into 100,000 shares of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs 5,100,000/- divided into 51,000 shares of Rs. 100/- each |
Details of Directors
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Sheikh Faisal Khalid Mr. Sheikh Muhammad Bilal Mrs. Musarat Parveen |
Pakistani Pakistani Pakistani |
Iqbal House, Abdara Revenue, Tehkal Payan, Peshawar Iqbal House, Abdara Revenue, Tehkal Payan, Peshawar Iqbal House, Abdara Revenue, Tehkal Payan, Peshawar |
Business Business House Wife |
Chief Executive Director Director |
Shareholders
|
Names |
Address |
No. of Shares |
|
Sheikh Faisal Khalid Sheikh Muhammad Bilal Mrs. Musarat Parveen |
Iqbal House, Abdara Revenue, Tehkal Payan, Peshawar Iqbal House, Abdara Revenue, Tehkal Payan, Peshawar Iqbal House, Abdara Revenue, Tehkal Payan, Peshawar |
17,000 17,000 17,000 |
Associates
A. Subsidiary
None
B. Associated Companies
- Do -
Business Activities
Manufacture & Marketing of Pharmaceutical Products
Number of Employees
56
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2006 |
15,000,000/- (Estimated) |
Agencies (Foreign)
Subject mainly imports pharmaceutical raw material from China, India, Germany & France
Customers
Mainly Individuals, Retailers, Pharmacies located in Peshawar, Quetta & Azad Kashmir
Bankers and their addresses
(1) Muslim Commercial Bank Limited, Khyber Bazar Branch, Peshawar, Pakistan.
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 60.85 |
|
UK Pound |
1 |
Rs. 122.20 |
|
Euro |
1 |
Rs. 87.10 |
Comments
Subject Company was established in 2001 and is engaged in manufacture & marketing of Pharmaceutical Products. Trade relations are reported as fair. Subject Company can be considered for normal business dealings at usual trade terms and condition.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)